in the Department of Neurology at the Mayo Clinic, said the theory is still considered plausible.
He reportedly told CBS News that PPIs may “alter enzymes in the brain” responsible for regulating amyloid – a protein strongly linked to the brain damage seen in Alzheimer’s disease.
According to him, the medications may “decrease the level of the body’s continue reading …